Analyst Profile

Followed by 228 followers
.
Silvan Tuerkcan

Silvan Tuerkcan

JMP Securities
Wall Street Analyst
#2,368 out of 8,141 Wall Street Analysts
#5,148 out of 24,284 experts

Success Rate

38%
51 out of 136 transactions made a profit

Average Return

+5.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Silvan Tuerkcan's trades since 2018 and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of 5.1% per rating.

Stock Rating Distribution

206Ratings
83.50% Buy
16.50% Hold
0.00% Sell
Distribution of Silvan Tuerkcan's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Constellation Pharma
(CNST)
Rating:Buy
Date:Jan 03, 2019 - Jan 03, 2020
Return:+800.00%
The most profitable rating made by Silvan Tuerkcan

Silvan Tuerkcan's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Sio Gene Therapies
Jun 07, 2018
Hold
Reiterated
1Ratings
0.00%
Seagen
Apr 30, 2020
Buy
Reiterated
$146.00
(24.39% Upside)
14Ratings
100%
+65.63%
Editas Medicine
May 07, 2020
Hold
Assigned
3Ratings
0.00%
CNST
Constellation Pharmaceuticals
May 14, 2020
Buy
Reiterated
11Ratings
50%
+161.46%
TPTX
Turning Point Therapeutics
Aug 10, 2022
Hold
Reiterated
12Ratings
0%
-47.00%
Relay Therapeutics
Sep 14, 2022
Buy
Reiterated
$38.00
(107.99% Upside)
11Ratings
22%
-19.62%
Logicbio Therapeutics
Oct 03, 2022
Hold
Downgraded
12Ratings
40%
+69.35%
MacroGenics
Nov 04, 2022
Buy
Reiterated
$18.00
(161.25% Upside)
10Ratings
44%
-4.76%
Exelixis
Nov 04, 2022
Buy
Reiterated
$26.00
(58.15% Upside)
16Ratings
69%
+7.25%
Cellectis SA
Nov 07, 2022
Buy
Reiterated
$11.00
(406.91% Upside)
11Ratings
20%
-34.14%
List of latest recommendations made by Silvan Tuerkcan. Click to expand and see Silvan Tuerkcan's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >